[
  {
    "ts": "2025-12-28T07:00:00+00:00",
    "headline": "Exxon’s CEO Is Positioning the Company to Operate Profitably for ‘Decades to Come’",
    "summary": "Exxon Mobil has raised its dividend for 43 consecutive years, and the payout looks safe even if crude falls to $40 a barrel.",
    "url": "https://www.barrons.com/articles/buy-exxon-mobil-stock-2026-c49ae06b?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "0b853c2d-c032-36f4-98b7-44464aba5635",
      "content": {
        "id": "0b853c2d-c032-36f4-98b7-44464aba5635",
        "contentType": "STORY",
        "title": "Exxon’s CEO Is Positioning the Company to Operate Profitably for ‘Decades to Come’",
        "description": "",
        "summary": "Exxon Mobil has raised its dividend for 43 consecutive years, and the payout looks safe even if crude falls to $40 a barrel.",
        "pubDate": "2025-12-28T07:00:00Z",
        "displayTime": "2025-12-28T07:00:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0b853c2d-c032-36f4-98b7-44464aba5635/exxon%E2%80%99s-ceo-is-positioning.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/4a541daa1d182d7943be86f1cbc69360",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q5MssnwcO.WzzxL22F13FA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/4a541daa1d182d7943be86f1cbc69360.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/X3hu3wDvL487iUSn8aRPDA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/4a541daa1d182d7943be86f1cbc69360.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/buy-exxon-mobil-stock-2026-c49ae06b?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "XOM"
            },
            {
              "symbol": "MS"
            },
            {
              "symbol": "MS-PQ"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "GC=F"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-28T15:05:40+00:00",
    "headline": "Morgan Stanley Eyes Emerging Growth for Grail (GRAL) as Sector Valuations Reach Equilibrium",
    "summary": "Grail Inc. (NASDAQ:GRAL) is one of the best emerging technology stocks to invest in. On December 1, Morgan Stanley assumed coverage of Grail with an Equal Weight rating and a price target of $110, which was up from $85. Heading into 2026, the firm is optimistic about the Life Science space, noting several emerging growth […]",
    "url": "https://finance.yahoo.com/news/morgan-stanley-eyes-emerging-growth-150540524.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ddd1c462-7680-3673-ab8f-594f53de0930",
      "content": {
        "id": "ddd1c462-7680-3673-ab8f-594f53de0930",
        "contentType": "STORY",
        "title": "Morgan Stanley Eyes Emerging Growth for Grail (GRAL) as Sector Valuations Reach Equilibrium",
        "description": "",
        "summary": "Grail Inc. (NASDAQ:GRAL) is one of the best emerging technology stocks to invest in. On December 1, Morgan Stanley assumed coverage of Grail with an Equal Weight rating and a price target of $110, which was up from $85. Heading into 2026, the firm is optimistic about the Life Science space, noting several emerging growth […]",
        "pubDate": "2025-12-28T15:05:40Z",
        "displayTime": "2025-12-28T15:05:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/1ea768ec4636ee6545f00685abc4f87e",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Morgan Stanley Eyes Emerging Growth for Grail (GRAL) as Sector Valuations Reach Equilibrium",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QsUnj2CY_Wi3UuFlFXy4BA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/1ea768ec4636ee6545f00685abc4f87e.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/i6lZZhH7TUOVnezMetGgZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/1ea768ec4636ee6545f00685abc4f87e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/morgan-stanley-eyes-emerging-growth-150540524.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/morgan-stanley-eyes-emerging-growth-150540524.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MS"
            },
            {
              "symbol": "GRAL"
            },
            {
              "symbol": "LABS.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-28T17:46:13+00:00",
    "headline": "Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential",
    "summary": "GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the cheap penny stocks to invest in. On December 18, Morgan Stanley lowered the firm’s price target on GoodRx to $4 from $5 and kept an Equal Weight rating on the shares. In a 2026 outlook for the Healthcare Services sector, the firm highlighted a strong environment for […]",
    "url": "https://finance.yahoo.com/news/morgan-stanley-favors-goodrx-gdrx-174613498.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "5ba76207-2f25-322a-adc7-5ce9a74ebebd",
      "content": {
        "id": "5ba76207-2f25-322a-adc7-5ce9a74ebebd",
        "contentType": "STORY",
        "title": "Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential",
        "description": "",
        "summary": "GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the cheap penny stocks to invest in. On December 18, Morgan Stanley lowered the firm’s price target on GoodRx to $4 from $5 and kept an Equal Weight rating on the shares. In a 2026 outlook for the Healthcare Services sector, the firm highlighted a strong environment for […]",
        "pubDate": "2025-12-28T17:46:13Z",
        "displayTime": "2025-12-28T17:46:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/95fd81d4f5d040c938c24d040b7928f6",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CIUGVWX04aodX5gd9kEDXg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/95fd81d4f5d040c938c24d040b7928f6.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DFimZdPOaVdJ93jDJvn9fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/95fd81d4f5d040c938c24d040b7928f6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/morgan-stanley-favors-goodrx-gdrx-174613498.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/morgan-stanley-favors-goodrx-gdrx-174613498.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GDRX"
            },
            {
              "symbol": "MS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]